Cellyan Biotechnology (HKPD) vs 111 (YI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
111 is the larger company by market cap ($27.6 million vs $5.0 million), about 5.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HKPD | YI |
|---|---|---|
| Share price | $0.1008 | $3.14 |
| Market cap | $4.97M | $27.62M |
| 1-day change | -2.80% | -0.32% |
| YTD return | — | +22.66% |
| 1-year return | — | -34.45% |
| 5-year return | — | -44.42% |
| P/E ratio (TTM) | — | 0.31 |
| Forward P/E | — | 22.43 |
| EPS (TTM) | $-0.07 | $10.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $11.17 |
| 52-week low | $0.095 | $2.48 |
| Distance from 52-week high | -94.14% | -71.89% |
| Average volume | 3.78M | 11.12K |
| Shares outstanding | 42.17M | 5.20M |
| Employees | 11 | 1,063 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Medical Distribution |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- 111 is about 5.6 times larger than Cellyan Biotechnology by market value ($27.62M vs $4.97M).
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Healthcare · Medical Distribution · 11 employees
About 111
YI stock →111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B.
Healthcare · Medical Distribution · 1,063 employees
HKPD vs YI FAQ
Which is bigger, Cellyan Biotechnology or 111?
111 (YI) is larger, with a market capitalization of $27.62M compared with $4.97M for Cellyan Biotechnology (HKPD).
Are Cellyan Biotechnology and 111 in the same industry?
Yes. Both are classified in the Medical Distribution industry within the Healthcare sector.